Improvement of dyskinesias with l-dopa infusion in advanced Parkinson's disease.

Research output: Contribution to journalArticle

Abstract

We wanted to investigate whether continuous intrajejunal levodopa-carbidopa intestinal gel (LCIG) therapy has an antidyskinetic effect in patients with Parkinson's disease (PD) and troublesome dyskinesias. We also sought to examine the effect of LCIG therapy on motor function and health-related quality of life (HRQoL).

Details

Authors
Organisations
External organisations
  • Central Hospital Bremerhaven
  • Carlos III Health Institute
  • San Camillo Hospital
  • King's College London
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurology
Original languageEnglish
JournalActa Neurologica Scandinavica
Early online date2015 Sep 11
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes